340B Provider Reforms Gaining Momentum In Congress

House Energy & Commerce Committee recommends more oversight of hospital participation in the 340B drug discount program.

Syringes stuck in a dartboard

Congressional reform of the 340B outpatient prescription drug discount program is gathering momentum with the release of a report by the House Energy & Commerce Committee Jan. 10.

The report, which caps a two-year investigation, makes a number of recommendations to address concerns that oversight of 340B by...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access